MAPT and Alzheimer disease: Supporting this hypothesis, abnormally-phosphorylated tau (p-tau) has been detected in AD tau aggregates using phospho-specific antibodies (Köpke et al., 1993; Braak and Braak, 1995; Augustinack et al., 2002).